The distribution of dynorphinergic terminals in striatal target regions in comparison to the distribution of substance P-containing and enkephalinergic terminals in monkeys and humans

Neuroscience

Volumn 88, Issue 3, 1999, Pages 775-793

  Reiner, A ^a   Medina, L ^a   Haber, S N ^b  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

Dynorphin; Enkephalin; Pallidum; Striatum; Substance P; Substantia nigra

Indexed keywords

DYNORPHIN; ENKEPHALIN; LEUCINE ENKEPHALIN; METENKEPHALIN; NEUROKININ A; SUBSTANCE P;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CORPUS STRIATUM; EXTRAPYRAMIDAL SYNDROME; GLOBUS PALLIDUS; HUMAN; HUMAN TISSUE; HUNTINGTON CHOREA; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; NERVE ENDING; NERVE FIBER; NERVE PROJECTION; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; RHESUS MONKEY; SUBSTANTIA NIGRA; TISSUE DISTRIBUTION;

EID: 0032889856     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(98)00254-1     Document Type: Article

References (108)

1. Albin R. L., Young A. B. and Penney J. B. (1989) The functional anatomy of basal ganglia disorders. Trends Neurosci. 12, 366-375.
2. Albin R. L., Reiner A., Anderson K. D., Penney J. B. and Young A. B. (1990) Striatal and nigral neuron subpopulations in rigid Huntington's disease: implications for the functional anatomy of chorea and rigidity-akinesia. Ann. Neurol. 27, 357-365.
3. Albin R. L., Young A. B., Penney J. B., Handelin B., Balfour R., Anderson K. D., Markel D. S., Tourtellotte W. W. and Reiner A. (1990) Striatal enkephalinergic abnormalities and N-methyl-D-aspartate receptor abnormalities in a case of presymptomatic Huntington's disease. New Engl. J. Med. 322, 1293-1298.
4. Albin R. L., Reiner A., Anderson K. D., Dure L. S. IV, Handelin B., Balfour R., Whetsell W. O. Jr, Penney J. B. and Young A. B. (1992) Preferential loss of striato-external pallidal and striato-nigral projection neurons in presymptomatic Huntington's disease. Ann. Neurol. 31, 425-430.
5. Anderson K. D. and Reiner A. (1990) The extensive co-occurrence of substance P and dynorphin in striatal projection neurons: an evolutionarily conserved feature of basal ganglia organization. J. comp. Neurol. 295, 339-369.
6. Bannon M. J., Poosch M. S., Haverstick D. M., Mandal A., Xue I. C. H., Shibata K. and Dragovic L. J. (1992) Preprotachykinin gene expression in the human basal ganglia: characterization of mRNAs and pre-mRNAs produced by alernate RNA splicing. Molec. Brain Res. 12, 225-231.
7. Baruch P., Artaud F., Godeheu G., Barbeito L., Glowinski J. and Cheramy A. (1988) Substance P and neurokinin A regulate by different mechanisms dopamine release from dendrites and nerve terminals of the nigrostriatal dopaminergic neurons. Neuroscience 25, 889-898.
8. Beckstead R. M. and Cruz C. J. (1986) Striatal axons to the globus pallidus, entopeduncular nucleus and substantia nigra come mainly from separate cell populations in cat. Neuroscience 19, 147-158.
9. Besson M. J., Graybiel A. M. and Quinn B. (1990) Coexpression of neuropeptides in the cat's striatum: an immunohistochemical study of substance P, dynorphin B and enkephalin. Neuroscience 39, 33-58.
10. Carraway R. E., Mitra S. P. and Duke G. E. (1993) A common precursor to neurotensin and LANT6 and its differential processing in chicken tissues. Peptides 14, 1245-1251.
11. Chai L., Choi W. S. and Rönnekleiv O. K. (1997) Maternal cocaine treatment alters dynorphin and enkephalin mRNA expression in brains of fetal rhesus macaques. J. Neurosci. 17, 1112-1121.
12. Chang H. T., Wilson C. J. and Kitai S. T. (1981) Single neostriatal efferent axons in the globus pallidus: a light and electron microscopic study. Science 213, 915-918.
13. Chen Q., Veenman C. L., Knopp K., Yan Z., Medina L., Song W. J., Surmeier D. J. and Reiner A. (1997) Evidence for the preferential localization of G1uR1 subunits of AMPA receptors to the dendritic spines of medium spiny neurons in rat striatum. Neuroscience 83, 749-761.
14. Chesselet M. F. and Affolter H. U. (1987) Preprotachykinin messenger RNA detected by in situ hybridization in striatal neurons of the human brain. Brain Res. 410, 83-88.
15. Chesselet M. F. and Delfs J. M. (1996) Basal ganglia and movement disorders: an update. Trends Neurosci. 19, 417-422.
16. Chesselet M. F. and Graybiel A. M. (1983) Met-enkephalin-like and dynorphin-like immunoreactivities of the basal ganglia of the cat. Life Sci. 33, 37-40.
17. Chesselet M. F., Weiss L., Wuenschell C., Tobin A. J. and Affolter H. U. (1987) Comparative distribution of the mRNAs for glutamic acid decarboxylase, tyrosine hydroxylase and tachykinins in the basal ganglia: an in situ hydridization study in the rodent brain. J. comp. Neurol. 262, 125-140.
18. Christensson-Nylander I., Herrera-Marschitz M., Staines W., Hokfelt T., Terenius L., Ungerstedt U., Cuello A. C., Oertel W. H. and Goldstein M. (1986) Striato-nigral dynorphin and substance P pathways in the rat. I. Biochemical and immunohistochemical studies. Expl Brain Res. 64, 169-192.
19. Civelli O., Douglass J., Goldstein A. and Herbert E. (1985) Sequence and expression of the rat prodynorphin gene. Proc. natn. Acad. Sci. U.S.A. 82, 4291-4295.
20. Crossman A. R. (1987) Primate models of dyskinesia: the experimental approach to the study of basal ganglia-related involuntary movement disorders. Neuroscience 21, 1-40.
21. Crossman A. R., Clarke C. E., Boyce S., Robertson R. G. and Sambrook M. A. (1987) MPTP-induced Parkinsonism in the monkey: neurochemical pathology, complications of treatment and pathophysiological mechanisms. Can. J. neurol. Sci. 14, 428-435.
22. Cuello A. C., Galfre G. and Milstein C. (1979) Detection of substance P in the central nervous system by a monoclonal antibody. Proc. natn. Acad. Sci. U.S.A. 76, 3532-3536.
23. Cuello A. C., Milstein C., Coutre R., Wright B., Priestley J. V. and Jarvis J. (1984) Characterization and immunocytochemical application of monoclonal antibodies against enkephalins. J. Histochem. Cytochem. 32, 947-957.
24. DeLong M. R. (1990) Primate models of movement disorders of basal ganglia origin. Trends Neurosci. 13, 281-285.
25. Dewar D., Jenner P. and Marsden C. D. (1985) Behavioural effects in rats of unilateral and bilateral injections of opiate receptor agonists into the globus pallidus. Neuroscience 15, 41-46.
26. DiFiglia M., Aronin N. and Martin J. B. (1982) Light and electron microscopic localization of immunoreactive leu-enkephalin in the monkey basal ganglia. J. Neurosci. 2, 303-320.
27. Emson P. C., Arrequi A., Clement V. J., Sandberg B. E. B. and Rossor M. (1980) Regional distribution of methionine-enkephalin and substance P-like immunoreactivity in normal human brain and in Huntington's disease. Brain Res. 199, 147-160.
28. Erichsen J. T., Reiner A. and Karten H. J. (1982) The co-occurrence of substance P-like and leucine-enkephalin-like immunoreactivities in neurons and fibers of the avian nervous system. Nature 295, 407-410.
29. Feger J. and Crossman A. R. (1984) Identification of different subpopulations of neostriatal neurones projecting to globus pallidus or substantia nigra in the monkey: a retrograde fluorescence double-labeling study. Neurosci. Lett. 49, 7-12.
30. Fenelon G., Francois C., Percheron G. and Yelnik J. (1990) Topographic distribution of pallidal neurons projecting to the thalamus in macaques. Brain Res. 520, 27-35.
31. Frey J. M. and Huffman R. D. (1985) Effects of enkephalin and morphine on rat globus pallidus neurons. Brain Res. Bull. 14, 251-259.
32. Gaspar P., Berger B., Gay M., Hamon M., Cesselin F., Vigny A., Javoy-Agid F. and Agid Y. (1983) Tyrosine hydroxylase and methionine-enkephalin in the human mesencephalon. J. neurol. Sci. 58, 247-267.
33. George S. R. and Kertesz M. (1987) Met-enkephalin concentrations in striatum respond reciprocally to alterations in dopamine neurotransmission. Peptides 8, 487-492.
34. Gerfen C. R. (1992) The neostriatal mosaic: multiple levels of compartmental organization in the basal ganglia. A. Rev. Neurosci. 15, 285-320.
35. Gerfen C. R. and Young W. S. III (1988) Distribution of striatonigral and striatopallidal peptidergic neurons in both patch and matrix compartments: an in situ hybridization histochemistry and fluorescent retrograde tracing study. Brain Res. 460, 161-167.
36. Gerfen C. R., Engber T. M., Mahan L. C., Susel Z., Chase T. N., Monsma F. J. Jr and Sibley D. R. (1990) D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons. Science 250, 1429-1432.
37. Gerfen C. R., McGinty J. F. and Young W. S. III (1991) Dopamine differentially regulates dynorphin, substance P and enkephalin expression in striatal neurons: in situ hybridization histochemical analysis. J. Neurosci. 11, 1016-1031.
38. 8. Neurosci. Lett. 46, 223-228.
39. Graybiel A. M. (1990) Neurotransmitters and neuromodulators in the basal ganglia. Trends Neurosci. 13, 244-253.
40. Graybiel A. M. and Chesselet M. F. (1984) Compartmental distribution of striatal cell bodies expressing [Met]enkephalin-like immunoreactivity. Proc. natn. Acad. Sci. U.S.A. 81, 7980-7984.
41. Haber S. and Eide R. (1981) Correlation between met-enkephalin and substance P immunoreactivity in the primate globus pallidus. Neuroscience 6, 1291-1297.
42. Haber S. and Elde R. (1982) The distribution of enkephalin immunoreactive fibers and terminals in the monkey central nervous system: an immunohistochemical study. Neuroscience 7, 1049-1095.
43. Haber S. N. and Groenewegen H. J. (1989) Interrelationship of the distribution of neuropeptides and tyrosine hydroxylase immunoreactivity in the human substantia nigra. J. comp. Neurol. 290, 53-68.
44. Haber S. N. and Lu W. (1995) Distribution of preproenkephalin messenger RNA in the basal ganglia and limbic-associated regions of the monkey telencephalon. Neuroscience 65, 417-429.
45. Haber S. N. and Nauta W. J. H. (1983) Ramifications of the globus pallidus in the rat as indicated by patterns of immunohistochemistry. Neuroscience 9, 245-260.
46. Haber S. N. and Watson S. J. (1985) The comparative distribution of enkephalin, dynorphin and substance P in the human globus pallidus and basal forebrain. Neuroscience 14, 1011-1024.
47. Harlan R. E., Garcia M. M. and Krause J. E. (1989) Cellular localization of substance P- and neurokinin A-encoding preprotachykinin mRNA in the female rat brain. J. comp. Neurol. 287, 179-212.
48. Hazrati L.-N. and Parent A. (1992) The striatopallidal projection displays a high degree of anatomical specificity in the primate. Brain Res. 592, 213-227.
49. Herrera-Marschitz M., Hokfelt T., Ungerstedt U., Terenius L. and Goldstein M. (1984) Effect of intranigral injections of dynorphin, dynorphin fragments and alpha-neoendorphin on rotational behaviour in the rat. Eur. J. Pharmac. 102, 213-227.
50. Herrera-Marschitz M., Christensson-Nylander I., Sharp T., Staines W., Reid M., Hokfelt T., Terenius L. and Ungerstedt U. (1986) Striato-nigral dynorphin and substance P pathways in the rat. II. Functional analysis. Expl Brain Res. 64, 193-207.
51. Hong J. S., Yoshikawa K., Kanamatsu T. and Sabol S. L. (1985) Modulation of striatal enkephalinergic neurons by antipsychotic drugs. Fedn Proc. 44, 2535-2539.
52. Hosokawa S. and Kato M. (1986) Physiology of peptides in basal ganglia. In Progress in Brain Research (eds Emson P. C., Rossor M. N. and Tohyama M.), Vol. 66, pp. 73-89. Elsevier, New York.
53. Hurd Y. L. and Herkenham M. (1995) The human neostriatum shows compartmentalization of neuropeptide gene expression in dorsal and ventral regions: an in situ hybridization histochemical analysis. Neuroscience 64, 571-586.
54. Inagaki S., Kubota Y. and Kito S. (1986) Ultrastructural localization of enkephalin immunoreactivity in the substantia nigra of the monkey. Brain Res. 362, 171-174.
55. Kawaguchi Y., Wilson C. J. and Emson P. C. (1990) Projection subtypes of rat neostriatal matrix cells revealed by intracellular injection of biocytin. J. Neurosci. 10, 3238-3421.
56. Khachaturian H., Lewis M. E., Hollt V. and Watson S. J. (1983) Telencephalic enkephalinergic systems in the rat brain. J. Neurosci. 3, 844-855.
57. Khachaturian H., Lewis M. E., Schafer M. K. H. and Watson S. J. (1985) Anatomy of the CNS opioid systems. Trends Neurosci. 8, 111-119.
58. Khachaturian H., Lewis M. E., Haber S. N., Houghten R. A., Akil H. and Watson S. J. (1985) Prodynorphin peptide immunocytochemistry in rhesus monkey brain. Peptides 6, 155-166.
59. Kita H. and Kitai S. T. (1988) Glutamate decarboxylase immunoreactive neurons in rat neostriatum: their morphological types and populations. Brain Res. 447, 346-352.
60. Krause J. E., Chirgwin J. M., Carter M. S., Xu Z. S. and Hershey A. D. (1987) Three rat preprotachykinin mRNAs encode the neuropeptides substance P and neurokinin A. Proc. natn. Acad. Sci. U.S.A. 84, 881-885.
61. Lavin A. and Garcia-Munoz M. (1985) Electrophysiological changes in substantia nigra after dynorphin administration. Brain Res. 369, 298-302.
62. Lee J.-M., McLean S., Maggio J. E., Zamir N., Roth R. H., Eskay R. L. and Bannon M. J. (1986) The localization and characterization of substance P and substance K in striatonigral neurons. Brain Res. 371, 152-154.
63. Lee T., Kaneko T., Taki K. and Mizuno N. (1997) Preprodynorphin-, preproenkephalin, and preprotachykinin-expressing neurons in the rat neostriatum: an analysis by immunocytochemistry and retrograde tracing. J. comp. Neurol. 386, 229-244.
64. 1-8 in the striatonigral pathway by the dopaminergic system. Brain Res. 398, 390-392.
65. Lindefors N., Brodin E. and Ungerstedt U. (1986) Neurokinin A and substance P in striato-nigral neurons in rat brain. Neuropeptides 8, 127-132.
66. Manuef Y. P., Mitchell I. J., Crossman A. R. and Brotchie J. M. (1994) On the role of enkephalin cotransmission in the GABAergic striatal efferent to the globus pallidus. Expl Neurol. 125, 65-71.
67. Marshall P. E., Landis D. D. and Zalneratis E. L. (1983) Immunocytochemical studies of substance P and leucine-enkephalin in Huntington's disease. Brain Res. 289, 11-26.
68. Mitchell I. J., Jackson A., Sambrook M. A. and Crossman A. R. (1985) Common neural mechanisms in experimental chorea and hemiballismus in the monkey. Evidence from 2-deoxyglucose autoradiography. Brain Res. 339, 346-350.
69. 3H-2-deoxyglucose in the brain of the monkey during experimental choreiform dyskinesia elicited by injection of a gamma-aminobutyric acid antagonist into the subthalamic nucleus. Brain 108, 421-438.
70. Napier T. C., Pirch J. H. and Strahlendorf H. K. (1983) Naloxone antagonizes striatally-induced suppression of globus pallidus unit activity. Neuroscience 9, 53-59.
71. Nawa H., Hirose T., Takashima H., Inayama S. and Nakanishi S. (1983) Nucleotide sequences of cloned cDNA for two types of bovine brain substance P precursor. Nature 306, 32-36.
72. Normand E., Popovici T., Fellmann D. and Bloch B. (1987) Anatomical study of enkephalin gene expression in the rat forebrain following haloperidol treatment. Neurosci. Lett. 83, 232-236.
73. Normand E., Popovici T., Onteniente B., Fellmann D., Piatier-Tonneau D., Auffray C. and Bloch B. (1988) Dopaminergic neurons of the substantia nigra modulate preproenkephalin A gene expression in rat striatal neurons. Brain Res. 439, 39-46.
74. Nylander I. and Terenius L. H. (1987) Dopamine receptors mediate alterations in striato-nigral dynorphin and substance P pathways. Neuropharmacology 9, 1295-1302.
75. Oertel W. H. and Mugnaini E. (1984) Immunocytochemical studies of GABAergic neurons in rat basal ganglia and their relations to other neuronal systems. Neurosci. Lett. 47, 233-238.
76. Oertel W. H., Riethmuller G., Mugnaini E., Schmechel D. E., Weindl A., Gramsch C. and Herz A. (1983) Opioid peptide-like immunoreactivity localized in GABAergic neurons of rat neostriatum and central amygdaloid nucleus. Life Sci. 33, 73-76.
77. Parent A. (1986) Comparative Neurobiology of the Basal Ganglia. John Wiley and Sons, New York.
78. Parent A., Bouchard C. and Smith Y. (1984) The striatopallidal and striatonigral projections: two distinct fiber systems in primate. Brain Res. 303, 385-390.
79. Parent A. and De Bellefeuille L. (1982) Organization of efferent projections from the internal segment of globus pallidus as revealed by fluorescence retrograde labeling method. Brain Res. 245, 201-213.
80. Parent A. and De Bellefeuille L. (1983) The pallidointralaminar and pallidonigral projections in primate as studied by retrograde double-labeling method. Brain Res. 278, 11-27.
81. Parent A. and Hazrati L.-N. (1993) Anatomical aspects of information processing in primate basal ganglia. Trends Neurosci. 16, 111-116.
82. Parent A., Smith Y., Filion M. and Dumas J. (1989) Distinct afferents to internal and external pallidal segments in the squirrel monkey. Neurosci. Lett. 96, 140-144.
83. Penney J. B. Jr and Young A. B. (1986) Striatal inhomogeneities and basal ganglia function. Movement Disord. 1, 3-15.
84. Penny G. R., Afsharpour S. and Kitai S. T. (1986) The glutamate decarboxylase-, leucine enkephalin-, methionine enkephalin- and substance P-immunoreactive neurons in the neostriatum of the rat and cat: evidence for partial population overlap. Neuroscience 17, 1011-1045.
85. Pickel V. M., Sumal K. K., Beckley S. C., Miller R. J. and Reis D. J. (1980) Immunocytochemical localization of enkephalin in the neostriatum of rat brain: a light and electron microscopic study. J. comp. Neurol. 189, 721-740.
86. Porrino L. J., Burns R. S., Crane A., Palombo E., Kopin I. J. and Sokoloff L. (1987) Changes in local cerebral glucose utilization associated with Parkinson's syndrome induced by MPTP in the primate. Life Sci. 40, 1647-1664.
87. Reid M., Herrera-Marschitz M., Hokfelt T., Terenius L. and Ungerstedt U. (1988) Differential modulation of striatal dopamine release by intranigral injection of gamma-aminobutyric acid (GABA), dynorphin A and substance P. Eur. J. Pharmac. 147, 411-420.
88. Reiner A. (1986) The co-occurrence of substance P-like immunoreactivity and dynorphin-like immunoreactivity in striatonigral and striatopallidal projection neurons in pigeons and turtles. Brain Res. 371, 155-161.
89. Reiner A. (1987) The distribution of proenkephalin-derived neuropeptides in the central nervous system of turtle. J. comp. Neurol. 259, 65-91.
90. Reiner A. (1987) A LANT6-like peptide that is distinct from Neuromedin N is present in striatal and pallidal neurons in the monkey basal ganglia. Brain Res. 422, 186-191.
91. Reiner A. and Anderson K. D. (1990) The patterns of neurotransmitter and neuropeptide co-occurrence among striatal projection neurons: conclusions based on recent findings. Brain Res. Rev. 15, 251-265.
92. Reiner A., Albin R. L., Anderson K. D., D'Amato C. J., Penney J. B. and Young A. B. (1988) Differential loss of striatal projection neurons in Huntington's disease. Proc. natn. Acad. Sci. U.S.A. 85, 5733-5737.
93. Selemon L. D. and Goldman-Rakic P. S. (1990) Topographic intermingling of striatonigral and striatopallidal neurons in the rhesus monkey. J. comp. Neurol. 197, 359-376.
94. Smith Y. and Parent A. (1986) Differential connections of caudate nucleus and putamen in the squirrel monkey (Saimiri sciureus). Neuroscience 18, 347-371.
95. Surmeier D. J., Eberwine J., Wilson C. J., Cao Y., Stefani A. and Kitai S. T. (1992) Dopamine receptor subtypes colocalize in rat striatonigral neurons. Proc. natn. Acad. Sci. U.S.A. 89, 10178-10182.
96. Surmeier D. J., Reiner A., Levine M. S. and Ariano M. A. (1993) Are neostriatal dopamine receptors co-localized? Trends Neurosci. 16, 299-305.
97. Surmeier D. J., Song W. J. and Yan Z. (1996) Coordinated expression of dopamine receptors in neostriatal medium spiny neurons. J. Neurosci. 16, 6579-6591.
98. Tang F., Costa E. and Schwartz J. P. (1983) Increase of proenkephalin mRNA and enkephalin content of rat striatum after daily injection of haloperidol for 2 to 3 weeks. Proc. natn. Acad. Sci. U.S.A. 80, 3841-3844.
99. Trujillo K. A. and Akil H. (1989) Changes in prodynorphin peptide content following treatment with morphine or amphetamine: possible role in mechanisms of action of drug abuse. NIDA Res. Monogr. 95, 550-551.
100. Uhl G. R., Navia B. and Douglas J. (1988) Differential expression of preproenkephalin and preprodynorphin mRNAs in striatal neurons: high levels of preproenkephalin expression depend on cerebral cortical afferents. J. Neurosci. 8, 4755-4764.
101. Vincent S. R., Hokfelt T., Christensson I. and Terenius L. (1982) Immunohistochemical evidence for a dynorphin immunoreactive striatonigral pathway. Eur. J. Pharmac. 85, 251-252.
102. Vincent S. R., Hokfelt T., Christensson I. and Terenius L. (1982) Dynorphin-immunoreactive neurons in the central nervous system of the rat. Neurosci. Lett. 33, 185-190.
103. Walker J. M., Thompson L. A., Frascella J. and Friederich M. W. (1987) Opposite effects of mu and kappa opiates on the firing-rate of dopamine cells in the substantia nigra of the rat. Eur. J. Pharmac. 134, 53-59.
104. Waters C. M., Peck R., Rossor M., Reynolds G. P. and Hunt S. P. (1988) Immunocytochemical studies on the basal ganglia and substantia nigra in Parkinson's disease and Huntington's chorea. Neuroscience 25, 419-438.
105. Wessendorf M. W. and Eide R. P. (1985) Characterization of an immunofluorescence technique for the demonstration of co-existing neurotransmitters within nerve fibers and terminals. J. Histochem. Cytochem. 33, 984-994.
106. 7-like peptides revealed by immunohistochemistry. Brain Res. 240, 167-170.
107. 7. Neuroscience 9, 563-586.
108. Zahm D. S., Zaborszky L., Alones V. E. and Heimer L. (1985) Evidence for the co-existence of glutamate decarboxylase and Met-enkephalin immunoreactivities in axon terminals of rat ventral pallidum. Brain Res. 325, 317-321.